Tumor-associated blood vessel stabilization by endothelial S1PR1 appeared to shift the tumor immune profile from myeloid towards lymphoid cells [118], although it is not clear if that relies on differences in diapedesis across leaky versus stabilized blood vessels. This evidence concerns the gene S1PR1 and neoplasm.